Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

For the first time, in this atlas nuclear physicians and radiologists cover the entire hybrid nuclear medicine (PET/CT, SPECT/CT and PET/MRI), based on their own case studies. The structure in three volumes represents an user friendly guide for interpreting PET and SPECT in relation to co-registered CT and/or MRI. Three companion volumes with a practical structure in two-page unit offer to the reader a navigational tool, based on anatomical districts, with labeled and explained low-dose multiplanar CT or MRI views merged with PET fusion imaging on the right hand and contrast enhanced CT or MRI on the other side. This new format enables rapid identification of hybrid nuclear medicine findings which are now routine at leading medical centers. Volume 1 is focused on brain and neck PET imaging, with emphasis on PET/MRI; Volume 2 concerns thorax, abdomen and pelvis, with particular attention on lung and liver segmental anatomy and evaluation of peritoneum. Special chapters on heart, lymph nodes and musculoskeletal system, are collected in the Volume 3. Each chapter begins with three-dimensional CT and/or MRI views of the evaluated anatomical region, bringing forward sectional tables. Clinical cases, tricks and pitfalls linked to several PET or SPECT radiopharmaceuticals help to introduce the reader to peculiar molecular pathways and to improve confidence in cross-sectional imaging, that is vital for the accurate diagnosis and treatment of diseases. Compact, comprehensive, easy to read guide to sectional imaging and multiplanar evaluation of hybrid PET and SPECT Includes 856 fully colored, labeled, high quality original images of axial, coronal and sagittal CT, contrast enhanced CT, PET/CT and/or PET/MRI Displays 200 clinical cases, showcasing both common and unusual findings that nuclear physicians and radiologists could encounter in their clinical practice Costant orthogonal references on 3D images allow orientation on axial, coronal and sagittal views Peculiar aspects of 18 PET and SPECT radiopharmaceuticals, defined by distinctive color scales Terms and descriptions mostly based on Terminologia Anatomica Specific text boxes explain anatomical variants, radiological advices and physiological findings linked to tracer bio-distribution Supports interpretation and report of hybrid nuclear medicine scans For professionals and vocationals.

Brain --- Positron Emission Tomography Computed Tomography. --- Magnetic Resonance Imaging --- Single Photon Emission Computed Tomography Computed Tomography. --- Anatomy, Cross-Sectional. --- Neck --- anatomy & histology. --- Cross-Sectional Anatomy --- Sectional Anatomy --- Anatomy, Sectional --- Anatomy, Cross Sectional --- Cross Sectional Anatomy --- Tomography --- Ultrasonography --- CT SPECT --- CT SPECT Scan --- SPECT CT --- SPECT CT Scan --- CT SPECT Scans --- CT SPECTs --- CT Scan, SPECT --- CT Scans, SPECT --- SPECT CT Scans --- SPECT Scan, CT --- SPECT Scans, CT --- SPECT, CT --- SPECTs, CT --- Scan, CT SPECT --- Scan, SPECT CT --- Scans, CT SPECT --- Scans, SPECT CT --- Functional Magnetic Resonance Imaging --- Imaging, Chemical Shift --- Proton Spin Tomography --- Spin Echo Imaging --- Steady-State Free Precession MRI --- Tomography, MR --- Zeugmatography --- Chemical Shift Imaging --- MR Tomography --- MRI Scans --- MRI, Functional --- Magnetic Resonance Image --- Magnetic Resonance Imaging, Functional --- Magnetization Transfer Contrast Imaging --- NMR Imaging --- NMR Tomography --- Tomography, NMR --- Tomography, Proton Spin --- fMRI --- Chemical Shift Imagings --- Echo Imaging, Spin --- Echo Imagings, Spin --- Functional MRI --- Functional MRIs --- Image, Magnetic Resonance --- Imaging, Magnetic Resonance --- Imaging, NMR --- Imaging, Spin Echo --- Imagings, Chemical Shift --- Imagings, Spin Echo --- MRI Scan --- MRIs, Functional --- Magnetic Resonance Images --- Resonance Image, Magnetic --- Scan, MRI --- Scans, MRI --- Shift Imaging, Chemical --- Shift Imagings, Chemical --- Spin Echo Imagings --- Steady State Free Precession MRI --- Magnetic Resonance Spectroscopy --- Anatomy, Cross-Sectional --- CT PET --- CT PET Scan --- PET CT Scan --- PET-CT --- PET-CT Scan --- Positron Emission Tomography-Computed Tomography --- CT PET Scans --- CT Scan, PET --- CT Scans, PET --- PET CT Scans --- PET Scan, CT --- PET Scans, CT --- PET-CT Scans --- Scan, CT PET --- Scan, PET CT --- Scan, PET-CT --- Scans, CT PET --- Scans, PET CT --- Scans, PET-CT --- Magnetic resonance imaging. --- Clinical magnetic resonance imaging --- Diagnostic magnetic resonance imaging --- Functional magnetic resonance imaging --- Imaging, Magnetic resonance --- Medical magnetic resonance imaging --- MR imaging --- MRI (Magnetic resonance imaging) --- NMR imaging --- Nuclear magnetic resonance --- Nuclear magnetic resonance imaging --- Cross-sectional imaging --- Diagnostic imaging --- Imaging. --- Diagnostic use --- Imaging --- diagnostic imaging

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Atlas of Hybrid Imaging of the Thorax, Abdomen and Pelvis, Volume Two: Sectional Anatomy for PET/CT, PET/MRI and SPECT/CT provides a guide for interpreting PET and SPECT in relation to co-registered CT and/or MRI. In this atlas, exclusively dedicated to thorax, abdomen and pelvis, nuclear physicians and radiologists cover hybrid nuclear medicine based on their own case studies. The practical structure in two-page unit offers readers a navigational tool based on anatomical districts, with labeled and explained low-dose multiplanar CT or MRI views merged with PET fusion imaging on one side and enhanced CT or MRI on the other.

Positron Emission Tomography Computed Tomography. --- Magnetic Resonance Imaging --- Single Photon Emission Computed Tomography Computed Tomography. --- Anatomy, Cross-Sectional. --- Thorax. --- Abdomen. --- Pelvis. --- Pelvic Region --- Region, Pelvic --- Pelvimetry --- Abdomens --- Thoraces --- Chest --- Chests --- Thorace --- Cross-Sectional Anatomy --- Sectional Anatomy --- Anatomy, Sectional --- Anatomy, Cross Sectional --- Cross Sectional Anatomy --- Tomography --- Ultrasonography --- CT SPECT --- CT SPECT Scan --- SPECT CT --- SPECT CT Scan --- CT SPECT Scans --- CT SPECTs --- CT Scan, SPECT --- CT Scans, SPECT --- SPECT CT Scans --- SPECT Scan, CT --- SPECT Scans, CT --- SPECT, CT --- SPECTs, CT --- Scan, CT SPECT --- Scan, SPECT CT --- Scans, CT SPECT --- Scans, SPECT CT --- Functional Magnetic Resonance Imaging --- Imaging, Chemical Shift --- Proton Spin Tomography --- Spin Echo Imaging --- Steady-State Free Precession MRI --- Tomography, MR --- Zeugmatography --- Chemical Shift Imaging --- MR Tomography --- MRI Scans --- MRI, Functional --- Magnetic Resonance Image --- Magnetic Resonance Imaging, Functional --- Magnetization Transfer Contrast Imaging --- NMR Imaging --- NMR Tomography --- Tomography, NMR --- Tomography, Proton Spin --- fMRI --- Chemical Shift Imagings --- Echo Imaging, Spin --- Echo Imagings, Spin --- Functional MRI --- Functional MRIs --- Image, Magnetic Resonance --- Imaging, Magnetic Resonance --- Imaging, NMR --- Imaging, Spin Echo --- Imagings, Chemical Shift --- Imagings, Spin Echo --- MRI Scan --- MRIs, Functional --- Magnetic Resonance Images --- Resonance Image, Magnetic --- Scan, MRI --- Scans, MRI --- Shift Imaging, Chemical --- Shift Imagings, Chemical --- Spin Echo Imagings --- Steady State Free Precession MRI --- Magnetic Resonance Spectroscopy --- Anatomy, Cross-Sectional --- CT PET --- CT PET Scan --- PET CT Scan --- PET-CT --- PET-CT Scan --- Positron Emission Tomography-Computed Tomography --- CT PET Scans --- CT Scan, PET --- CT Scans, PET --- PET CT Scans --- PET Scan, CT --- PET Scans, CT --- PET-CT Scans --- Scan, CT PET --- Scan, PET CT --- Scan, PET-CT --- Scans, CT PET --- Scans, PET CT --- Scans, PET-CT --- Life sciences. --- Biosciences --- Sciences, Life --- Science --- Abdomen --- Pelvis --- Thorax --- Imaging --- diagnostic imaging

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This Special Issue is a collection of selected papers from the 3rd European Congress on Imaging Infection and Inflammation (www.nuclearmedicinediscovery.org/events.asp) and results of consensus sessions by major experts in the field including Nuclear Medicine physicians, Radiologists, Clinicians and microbiologists. The Journal of Clinical Medicine (JCM) provides an opportunity to publish data that were presented and discussed at the meeting in Rome in December 2019. One of the extremely important missions of this meeting was to present the recently published guidelines on diagnostic imaging of infections, and find a consensus agreement on some still controversial issues. With this in mind, the aim of the present Special Issue is to publish selected papers on: • Overviews on published guidelines • Review on recent development of diagnostic imaging of infections • Consensus document on the use of FDG and WBC in infections • Consensus document on the requirement for new radiopharmaceuticals for imaging bacteria

infection --- vascular graft --- multimodality imaging --- WBC scintigraphy --- FDG-PET/CT --- angio-CT --- personalized medicine --- spondylodiscitis --- spine infection --- MRI --- 18F-FDG PET/CT --- diabetic foot --- diagnosis --- FDG PET/CT --- polymeric nanoparticles --- PLGA --- optical imaging --- tumor targeting --- imaging --- [18F]FDG PET/CT --- fever of unknown origin --- FUO --- PET/CT --- 18F-FDG-PET/CT --- Infective endocarditis --- echocardiography --- computed tomography --- magnetic resonance imaging --- nuclear imaging --- positron emission tomography --- endocarditis team --- cardiac implantable electronic device --- bacteria --- radiopharmaceutical --- molecular imaging --- nuclear medicine --- prosthetic joint infection --- SPECT/CT --- radiology

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Despite being described for the first time more than 110 years ago, Chagas disease (caused by the parasite Trypanosoma cruzi) persists as one of the most neglected tropical diseases. This persistent neglect of those affected by this disease is evidenced by the ongoing scientific evidence gaps, the difficulty of incorporating new diagnostic and treatment technologies into the market, and public health failures to ensure timely access to diagnosis and treatment associated with the development of consistent surveillance and control actions. As a result, there is a high burden of morbidity and mortality, and poor quality of life, poverty, stigma, and a fear of death persist for affected people, both in endemic areas in Latin America, and in non-endemic areas. This book spans a variety of disciplines and contributes significantly to reducing the gap in scientific knowledge on Chagas disease, towards achieving the Sustainable Development Goals by 2030.

Medicine --- Chagas disease --- neglected tropical diseases --- migration --- healthcare rights --- mucosal leishmaniasis --- co-infection --- antimoniate therapy --- cardiomyopathy --- myocardial fibrosis --- myocardial sympathetic denervation --- inflammation --- sudden death --- cardiac magnetic resonance --- radionuclide imaging --- SPECT-CT --- PET-CT --- heart disease --- electrocardiogram --- disease progression --- stroke --- risk assessment --- Trypanosoma cruzi --- Triatoma infestans --- parasite prevalence --- coprophagy --- human illness --- neglected tropical disease --- global financing --- annual funding --- investments --- disease notification --- public policy --- neglected topical diseases --- healthcare access --- chagasic cardiomyopathy --- heart transplantation --- Chagas disease reactivation --- cardiac allograft rejection --- treatment of reactivation --- genome --- parasite --- neglected diseases --- heart transplant --- chagas disease reactivation --- Cohort studies --- Neglected diseases --- Dynamic programming --- cost of illness --- premature --- efficiency --- organizational --- life expectancy --- American trypanosomiasis --- Trypanosoma cruzi infection --- public health --- epidemiology --- prevention and control --- surveillance --- clinical research --- One Health --- Chagas disease --- neglected tropical diseases --- migration --- healthcare rights --- mucosal leishmaniasis --- co-infection --- antimoniate therapy --- cardiomyopathy --- myocardial fibrosis --- myocardial sympathetic denervation --- inflammation --- sudden death --- cardiac magnetic resonance --- radionuclide imaging --- SPECT-CT --- PET-CT --- heart disease --- electrocardiogram --- disease progression --- stroke --- risk assessment --- Trypanosoma cruzi --- Triatoma infestans --- parasite prevalence --- coprophagy --- human illness --- neglected tropical disease --- global financing --- annual funding --- investments --- disease notification --- public policy --- neglected topical diseases --- healthcare access --- chagasic cardiomyopathy --- heart transplantation --- Chagas disease reactivation --- cardiac allograft rejection --- treatment of reactivation --- genome --- parasite --- neglected diseases --- heart transplant --- chagas disease reactivation --- Cohort studies --- Neglected diseases --- Dynamic programming --- cost of illness --- premature --- efficiency --- organizational --- life expectancy --- American trypanosomiasis --- Trypanosoma cruzi infection --- public health --- epidemiology --- prevention and control --- surveillance --- clinical research --- One Health

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

undefined

Medicine. --- positron emission tomography --- head and neck neoplasms --- neovascularization --- pathologic --- PET/CT --- urothelial carcinoma --- bladder cancer --- upper tract urothelial carcinoma --- survival --- PET --- PSMA --- prostate --- DCFPyL --- DCFBC --- PSMA-1007 --- ovarian cancer --- relapse --- SUVmax --- targeted therapy --- prognosis --- soft tissue sarcoma (STS) --- pazopanib --- dynamic 18F-FDG PET/CT --- SUV --- two-tissue compartment model --- magnetic resonance imaging --- machine learning --- diffusion --- perfusion --- texture analysis --- squamous cell carcinoma of the head and neck --- diffusion-weighted imaging --- malignant pleural mesothelioma --- pleural dissemination --- empyema --- pleural effusion --- mCRPC --- SPECT/CT --- Computer-assisted diagnosis --- XOFIGO --- Therapy response assessment --- circulating miRNAs --- breast cancer --- imaging parameters --- PET/MRI --- biomarkers --- triple negative breast cancer --- VCAM-1 --- SPECT imaging --- sdAbs --- Hounsfield unit --- computed tomography --- adipose tissue --- precision oncology --- FDG-PET/CT --- PERCIST --- metastatic breast cancer --- prostate cancer --- 18F-FACBC --- recurrence --- meta-analysis --- review --- meningioma --- somatostatin receptor --- neuroimaging --- radionuclide therapy --- breast --- imaging --- marker --- radiomics --- Yin Yang 1 --- PDAC --- Mesothelin --- noninvasive imaging --- receptor status --- molecular imaging --- nuclear medicine --- guidelines --- overutilization --- epistemology --- consensus --- mantle cell lymphoma --- 18F-FDG PET/CT --- Deauville criteria --- Radium-223 --- FDG --- castrate resistant prostate cancer --- programmed cell death 1 receptor --- diagnostic imaging --- CTLA-4 Antigen --- Immunotherapy --- Adoptive --- radioactive tracers --- radionuclide imaging --- CD8-Positive T-Lymphocytes --- PI-RADS --- diffusion kurtosis imaging --- dynamic contrast-enhanced magnetic resonance imaging --- 68Gallium-PSMA PET/CT --- prostate-specific-antigen --- PSA kinetics thresholds --- biochemical recurrence --- optimal cutoff level --- non-small-cell lung cancer --- circulating tumor cells --- immunotherapy --- response to treatment --- head and neck cancer --- HPV --- EBV --- p16 --- Molecular imaging --- miRNA expression --- radiogenomics --- radiomic --- diagnosis --- biomarker --- glioblastoma --- radiation therapy --- MRI --- diffusion tensor imaging --- Hodgkin lymphoma --- diffuse large B-cell lymphoma --- staging --- response assessment --- locally advanced cervical cancer --- concurrent chemoradiotherapy --- treatment response --- follow up --- cystic tumor --- International Consensus Guidelines --- intraductal papillary mucinous neoplasms --- pancreatic neoplasms --- PD-1 --- PD-L1 --- response to therapy --- NSCLC --- positron-emission tomography --- single-photon emission computed tomography --- immune checkpoint inhibitors --- gold nanoparticle --- heat shock protein 70 --- spectral-CT --- positron emission tomography --- head and neck neoplasms --- neovascularization --- pathologic --- PET/CT --- urothelial carcinoma --- bladder cancer --- upper tract urothelial carcinoma --- survival --- PET --- PSMA --- prostate --- DCFPyL --- DCFBC --- PSMA-1007 --- ovarian cancer --- relapse --- SUVmax --- targeted therapy --- prognosis --- soft tissue sarcoma (STS) --- pazopanib --- dynamic 18F-FDG PET/CT --- SUV --- two-tissue compartment model --- magnetic resonance imaging --- machine learning --- diffusion --- perfusion --- texture analysis --- squamous cell carcinoma of the head and neck --- diffusion-weighted imaging --- malignant pleural mesothelioma --- pleural dissemination --- empyema --- pleural effusion --- mCRPC --- SPECT/CT --- Computer-assisted diagnosis --- XOFIGO --- Therapy response assessment --- circulating miRNAs --- breast cancer --- imaging parameters --- PET/MRI --- biomarkers --- triple negative breast cancer --- VCAM-1 --- SPECT imaging --- sdAbs --- Hounsfield unit --- computed tomography --- adipose tissue --- precision oncology --- FDG-PET/CT --- PERCIST --- metastatic breast cancer --- prostate cancer --- 18F-FACBC --- recurrence --- meta-analysis --- review --- meningioma --- somatostatin receptor --- neuroimaging --- radionuclide therapy --- breast --- imaging --- marker --- radiomics --- Yin Yang 1 --- PDAC --- Mesothelin --- noninvasive imaging --- receptor status --- molecular imaging --- nuclear medicine --- guidelines --- overutilization --- epistemology --- consensus --- mantle cell lymphoma --- 18F-FDG PET/CT --- Deauville criteria --- Radium-223 --- FDG --- castrate resistant prostate cancer --- programmed cell death 1 receptor --- diagnostic imaging --- CTLA-4 Antigen --- Immunotherapy --- Adoptive --- radioactive tracers --- radionuclide imaging --- CD8-Positive T-Lymphocytes --- PI-RADS --- diffusion kurtosis imaging --- dynamic contrast-enhanced magnetic resonance imaging --- 68Gallium-PSMA PET/CT --- prostate-specific-antigen --- PSA kinetics thresholds --- biochemical recurrence --- optimal cutoff level --- non-small-cell lung cancer --- circulating tumor cells --- immunotherapy --- response to treatment --- head and neck cancer --- HPV --- EBV --- p16 --- Molecular imaging --- miRNA expression --- radiogenomics --- radiomic --- diagnosis --- biomarker --- glioblastoma --- radiation therapy --- MRI --- diffusion tensor imaging --- Hodgkin lymphoma --- diffuse large B-cell lymphoma --- staging --- response assessment --- locally advanced cervical cancer --- concurrent chemoradiotherapy --- treatment response --- follow up --- cystic tumor --- International Consensus Guidelines --- intraductal papillary mucinous neoplasms --- pancreatic neoplasms --- PD-1 --- PD-L1 --- response to therapy --- NSCLC --- positron-emission tomography --- single-photon emission computed tomography --- immune checkpoint inhibitors --- gold nanoparticle --- heat shock protein 70 --- spectral-CT